Segment disclosures

Company overview

HEM파마

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 16 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-304574549685 KRW20260821Open filing evidence
2026-01-01 – 2026-06-309516001912 KRW20260821Open filing evidence
2026-01-01 – 2026-03-314941452227 KRW20260511Open filing evidence
2025-01-01 – 2025-12-3112979352490 KRW20260729Open filing evidence
2025-07-01 – 2025-09-302956028138 KRW20251128Open filing evidence
2025-01-01 – 2025-09-309309316614 KRW20251128Open filing evidence
2025-04-01 – 2025-06-302844579286 KRW20260821Open filing evidence
2025-01-01 – 2025-06-306353288476 KRW20260821Open filing evidence
2025-01-01 – 2025-03-313508709190 KRW20260511Open filing evidence
2024-01-01 – 2024-12-3115067336854 KRW20260729Open filing evidence
2024-07-01 – 2024-09-303223846014 KRW20251128Open filing evidence
2024-01-01 – 2024-09-308747150745 KRW20251128Open filing evidence
2024-04-01 – 2024-06-302934952730 KRW20250826Open filing evidence
2024-01-01 – 2024-06-305523304731 KRW20250826Open filing evidence
2024-01-01 – 2024-03-312588352001 KRW20250521Open filing evidence
2023-01-01 – 2023-12-315344041000 KRW20260729Open filing evidence